Precision Medicine in Kidney Disease

Dear Colleagues,

Precision medicine is redefining the way that we approach nephrology, moving from general therapeutic strategies to individualised treatment based on genetic, molecular, and clinical profiling. The heterogeneity of kidney disease requires customised interventions that go beyond “one-size-fits-all” models.

Over the last two decades, nephrology has seen an increasing integration of biomarkers, pharmacogenomics, and systems biology into clinical practice. This shift reflects the need to optimize outcomes in complex patient populations, particularly those with chronic kidney disease, glomerular disorders, and dialysis-dependent diseases.

This Special Issue aims to explore the full potential of precision medicine in nephrology. We look forward to contributions that demonstrate how new technologies, data analysis, and individualized therapeutic targets can improve the diagnosis, risk stratification, and response to treatment of kidney disease.

We are particularly interested in studies that use multi-omics, artificial intelligence, digital health platforms, or advanced imaging to develop predictive models, personalized drug delivery systems, or innovative stratification tools for nephrology patients.

We invite original research articles and reviews that address the implementation, challenges, and future directions of precision medicine in kidney disease—from bench to bedside.

Dr. Guido Gembillo
Guest Editor

Dr. Concetto Sessa
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.